Lexiscan and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexiscan (regadenoson) and Lantus (insulin glargine recombinant). Common drug interactions include arrhythmia among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Lexiscan and Lantus. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Lexiscan?

Lexiscan has active ingredients of regadenoson. eHealthMe is studying from 4,442 Lexiscan users. Check the latest studies of Lexiscan.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.



On Jul, 20, 2026

26 people who take Lexiscan and Lantus together, and have interactions are studied.

Lexiscan and Lantus drug interactions.

What are the common drug interactions of Lexiscan and Lantus, by gender? *:

female:

  1. Arrhythmia (irregular heartbeat)
  2. Cardiac arrest
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Cardiovascular disorder (heart diseases)
  6. Chest pain
  7. Atrioventricular block (heart block)
  8. Aphasia (damage to the parts of the brain that control language)
  9. Blood pressure decreased
  10. Diarrhoea

male:

  1. Dizziness
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Bradycardia (abnormally slow heart action)
  5. Presyncope
  6. Vomiting
  7. Atrioventricular block second degree (heart block second degree)
  8. Injection site extravasation (flow of (blood or lymph) from injection site)
  9. Injection site pain
  10. Tenderness (pain or discomfort when an affected area is touched)

What are the common drug interactions of Lexiscan and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiovascular disorder (heart diseases)
  2. Chest pain

50-59:

  1. Atrioventricular block (heart block)
  2. Injection site extravasation (flow of (blood or lymph) from injection site)
  3. Injection site pain
  4. Aphasia (damage to the parts of the brain that control language)
  5. Diarrhoea
  6. Dizziness
  7. Epistaxis (bleed from the nose)
  8. Headache (pain in head)
  9. Mood swings (an extreme or rapid change in mood)
  10. Nervousness

60+:

  1. Arrhythmia (irregular heartbeat)
  2. Cardiac arrest
  3. Hypotension (abnormally low blood pressure)
  4. Pulse absent
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Bradycardia (abnormally slow heart action)
  7. Chest pain
  8. Presyncope
  9. Atrioventricular block second degree (heart block second degree)
  10. Tenderness (pain or discomfort when an affected area is touched)

* Approximation only. Some reports may have incomplete information.

Do you take Lexiscan and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexiscan and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexiscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexiscan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on regadenoson and insulin glargine recombinant (the active ingredients of Lexiscan and Lantus, respectively), and Lexiscan and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: